Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…

The U.S. Food and Drug Administration (FDA) has named Terns Pharmaceuticals’ investigational oral agent TERN-701 a breakthrough therapy for potential use in certain people…

Almost a third of people with advanced pancreatic cancer taking part in an ongoing clinical trial had stable disease following treatment with the experimental…